Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|January 4, 2020
Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonistsZeping Zuo, Miaomiao Chen, Xiaoni Shao, et al.ACS Chemical Neuroscience|April 12, 2023
Cardiolipin and OPA1 Team up for Methamphetamine-Induced Locomotor Activity by Promoting Neuronal Mitochondrial Fusion in the Nucleus Accumbens of MiceLiang Wang, Qingfan Wei, Rui Xu, et al.Journal of Neuroscience Research|August 1, 2012
(1) H-nuclear magnetic resonance-based metabonomic analysis of brain in rhesus monkeys with morphine treatment and withdrawal interventionYi Deng, Qian Bu, Zhengtao Hu, et al.Cell Death & Disease|April 25, 2020
Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cellsJin Gong, Yiyun Lin, Huaqin Zhang, et al.Cancer & Metabolism|May 11, 2021
DHODH and cancer: promising prospects to be exploredYue Zhou, Lei Tao, Xia Zhou, et al.Cancer Letters|April 13, 2019
ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathwayYan Li, Lei Tao, Zeping Zuo, et al.European Journal of Medicinal Chemistry|July 1, 2023
Synthesis and biological evaluation of novel pyrazole amides as potent mitochondrial complex I inhibitorsYang Zhou, Jiao Zou, Xi Zhong, et al.Nature Communications|November 25, 2020
Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in miceWei Xu, Hongchun Li, Liang Wang, et al.Journal of Medicinal Chemistry|December 14, 2021
Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy TreatmentChungen Li, Xiaowei Yang, Yuan Luo, et al.BMC Cancer|July 19, 2015
A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activitiesYouzhi Xu, Wenjie Lu, Peng Yang, et al.Pageof 12